Adverse Drug Events by Sex After Adjusting for Baseline Rates of Drug Use

被引:3
|
作者
Rushovich, Tamara [1 ]
Gompers, Annika [2 ]
Lockhart, Jeffrey W. [3 ]
Omidiran, Ife [4 ]
Worthington, Steven [5 ]
Richardson, Sarah S. [6 ]
Lee, Katharine M. N. [7 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, 677 Huntington Ave, Boston, MA 02115 USA
[2] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA USA
[3] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA
[4] Harvard Univ, Cambridge, MA USA
[5] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA
[6] Harvard Univ, Cambridge, MA USA
[7] Tulane Univ, New Orleans, LA USA
关键词
D O I
10.1001/jamanetworkopen.2023.29074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This cross-sectional study examines adverse drug events reported by sex in the US Food and Drug Administration (FDA) database after adjusting for drug use by males and females.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] A Gender Hypothesis of sex disparities in adverse drug events
    Lee, Katharine M. N.
    Rushovich, Tamara
    Gompers, Annika
    Boulicault, Marion
    Worthington, Steven
    Lockhart, Jeffrey W.
    Richardson, Sarah S.
    [J]. SOCIAL SCIENCE & MEDICINE, 2023, 339
  • [2] INCREASING THE NUMBER OF ADVERSE DRUG EVENTS BY THE USE OF AN ADVERSE DRUG EVENT MANAGER (ADEM)
    Jimenez-Solem, E.
    Vinther, S.
    Harboe, K. M.
    Klarskov, P.
    Christensen, H. R.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : E165 - E165
  • [3] Adverse Drug Events after Kidney Transplantation
    Rostaing, Lionel
    Jouve, Thomas
    Terrec, Florian
    Malvezzi, Paolo
    Noble, Johan
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (12):
  • [4] High rates of adverse drug events in a highly computerized hospital
    Nebeker, JR
    Hoffman, JM
    Weir, CR
    Bennett, CL
    Hurdle, JF
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) : 1111 - 1116
  • [5] Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
    Kelly, W. N.
    Ho, M. J.
    Smith, T.
    Bullers, K.
    Bates, D. W.
    Kumar, A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (07)
  • [6] INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
    BATES, DW
    CULLEN, DJ
    LAIRD, N
    PETERSEN, LA
    SMALL, SD
    SERVI, D
    LAFFEL, G
    SWEITZER, BJ
    SHEA, BF
    HALLISEY, R
    VANDERVLIET, M
    NEMESKAL, R
    LEAPE, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01): : 29 - 34
  • [7] Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
    Yue Yu
    Jun Chen
    Dingcheng Li
    Liwei Wang
    Wei Wang
    Hongfang Liu
    [J]. Scientific Reports, 6
  • [8] Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
    Yu, Yue
    Chen, Jun
    Li, Dingcheng
    Wang, Liwei
    Wang, Wei
    Liu, Hongfang
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [9] Use of a spontaneous adverse drug events database for identification of unanticipated drug benefits
    Brinker, A
    Beitz, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (01) : 99 - 102
  • [10] Fluoroquinolone use and associated adverse drug events in England
    Baddour, Larry M.
    Dayer, Mark J.
    Thornhill, Martin H.
    [J]. JOURNAL OF INFECTION, 2019, 78 (03) : 251 - 253